Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma

Nuclear Medicine Communications

Volumn 33, Issue 7, 2012, Pages 719-725

  Sogawa, Chizuru ^a   Tsuji, Atsushi B ^a   Yoshida, Chisato ^a   Inubushi, Masayuki ^a   Furukawa, Takako ^a   Koizumi, Mitsuru ^a   Akahori, Yasushi ^b   Ukai, Yoshinori ^b   Kurosawa, Gene ^b   Kurosawa, Yoshikazu ^b   Saga, Tsuneo ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

antibody; epidermal growth factor receptor; hepatocellular carcinoma; human IgG; radiolabeling

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; INDIUM 111; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 048 006; MONOCLONAL ANTIBODY 048 040; MONOCLONAL ANTIBODY 054 101; MONOCLONAL ANTIBODY 055 147; MONOCLONAL ANTIBODY 057 091; MONOCLONAL ANTIBODY 059 152; MONOCLONAL ANTIBODY 059 173; MONOCLONAL ANTIBODY 067 149; MONOCLONAL ANTIBODY 067 176; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; ASSAY; CELL STRAIN HEPG2; COMPETITIVE INHIBITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMAGING; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; RECEPTOR AFFINITY; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84862234784     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283531d68     Document Type: Article

References (25)

1. Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1990; 265:7709-7712.
2. Arteaga C. Targeting HER1/EGFR: A molecular approach to cancer therapy. Semin Oncol 2003; 30:3-14.
3. Laskin JJ, Sandler AB. Epidermal growth factor receptor: A promising target in solid tumours. Cancer Treat Rev 2004; 30:1-17.
4. Starling N, Cunningham D. Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: Present and future directions. Curr Opin Oncol 2004; 16:385-390.
5. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000; 103:211-225.
6. GullickWJ. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 1991; 47:87-98.
7. Nunn AD. Molecular imaging and personalized medicine: An uncertain future. Cancer Biother Radiopharm 2007; 22:722-739.
8. Aerts HJ, Dubois L, Perk L, Vermaelen P, van Dongen GA,Wouters BG, et al. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET. J Nucl Med 2009; 50:123-131.
9. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
10. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16.
11. Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36:962-972.
12. Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA 2007; 104: 17081-17086.
13. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, et al. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 2008; 299: 53-60.
14. Komuves LG, Feren A, Jones AL, Fodor E. Expression of epidermal growth factor and its receptor in cirrhotic liver disease. J Histochem Cytochem 2000; 48:821-830.
15. Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008; 48:1312-1327.
16. Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010; 29:4989-5005.
17. Asnacios A, Fartoux L, Romano O, Tesmoingt C, Louafi SS, Mansoubakht T, et al. Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: Results of a multicenter phase 2 study. Cancer 2008; 112:2733-2739.
18. Seo S, Hatano E, Higashi T, Hara T, Tada M, Tamaki N, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 2007; 13:427-433.
19. Kurosawa G, Akahori Y, Morita M, Sumitomo M, Sato N, Muramatsu C, et al. Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic. Proc Natl Acad Sci USA 2008; 105:7287-7292.
20. Akahori Y, Kurosawa G, Sumitomo M, Morita M, Muramatsu C Eguchi K, et al. Isolation of antigen/antibody complexes through organic solvent (ICOS) method. Biochem Biophys Res Commun 2009; 378: 832-835.
21. Saga T, Endo K, Akiyama T, Sakahara H, Koizumi M, Watanabe Y, et al. Scintigraphic detection of overexpressed c-erbB-2 protooncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody. Cancer Res 1991; 51:990-994.
22. Sogawa C, Tsuji AB, Sudo H, Sugyo A, Yoshida C, Odaka K, et al. C-kittargeted imaging of gastrointestinal stromal tumor using radiolabeled anti-ckit monoclonal antibody in a mouse tumor model. Nucl Med Biol 2010; 37:179-187.
23. Yoshida C, Sogawa C, Tsuji AB, Sudo H, Sugyo A, Uehara T, et al. Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model. Nucl Med Commun 2010; 31:380-388.
24. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984; 72:77-89.
25. Saga T, Sakahara H, Yao Z, Nakamoto Y, Sato N, Hattori N, et al. Detection of altered adhesion molecule expression in experimental tumors by a radiolabeled monoclonal antibody. Jpn J Cancer Res 1997; 88:1171-1180.